GTSE1 was highly expressed in NPC, and silencing of GTSE1 ameliorated the malignant processes of NPC cells by upregulating STMN1, suggesting a possible therapeutical target for NPC. This evidence concerns the gene STMN1 and nasopharyngeal carcinoma.